[Role of CD36 in nonalcoholic fatty liver disease].
Zhonghua Gan Zang Bing Za Zhi
; 25(12): 953-956, 2017 Dec 20.
Article
em Zh
| MEDLINE
| ID: mdl-29325301
ABSTRACT
Nonalcoholic fatty liver disease (NAFLD) includes nonalcoholic simple fatty liver, nonalcoholic steatohepatitis, liver cirrhosis, and liver cancer and is the most common liver disease in the world. The complex pathogenesis of NAFLD is a major concern among researchers. CD36 is a transmembrane glycoprotein that takes up fatty acid and binds to oxidized low-density lipoprotein in the liver, and therefore, it is involved in the development and progression of NAFLD. With reference to the latest research findings, this article reviews the association between CD36 and NAFLD and the role of CD36.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Antígenos CD36
/
Hepatopatia Gordurosa não Alcoólica
/
Neoplasias Hepáticas
Limite:
Adult
/
Humans
Idioma:
Zh
Revista:
Zhonghua Gan Zang Bing Za Zhi
Assunto da revista:
GASTROENTEROLOGIA
Ano de publicação:
2017
Tipo de documento:
Article
País de afiliação:
China